# Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures

> **NCT03940326** · PHASE4 · COMPLETED · sponsor: **Mazandaran University of Medical Sciences** · enrollment: 103 (actual)

## Conditions studied

- Epilepsy, Idiopathic Generalized

## Interventions

- **DRUG:** Levetiracetam
- **DRUG:** Valproate

## Key facts

- **NCT ID:** NCT03940326
- **Lead sponsor:** Mazandaran University of Medical Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-01
- **Primary completion:** 2019-10-01
- **Final completion:** 2019-12-01
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03940326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03940326, "Levetiracetam Versus Valproate in Idiopathic Generalized Tonic-clonic Seizures". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03940326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*